Industry

– Approval Expands on Previous FDA Approval of Vemlidy in Adults Living With This Chronic Liver Disease – –Efficacy and Safety of Once-Daily Vemlidy Demonstrated in Individuals 12 Years of Age and Older – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the … [Read more…]

CareDx Showcases Latest Innovations in Pre- and Post-Transplant Patient Care BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will be sharing the latest data on AlloSure® Kidney and its patient-centered … [Read more…]

Third-Quarter 2022 Results: — Net Sales of $925.4 Million — — GAAP Net Income of $135.8 Million; Adjusted EBITDA of $335.3 Million, Which Includes $19.0 Million of Acquired IPR&D and Milestones Expenses — — TEPEZZA® (teprotumumab-trbw) Net Sales of $490.9 Million — — KRYSTEXXA® (pegloticase injection) Net Sales of $191.6 Million — — Cash Position … [Read more…]

– Third-Quarter Revenue of $989.2 Million – – Third-Quarter GAAP Earnings per Share of $1.88 and Non-GAAP Earnings per Share of $2.63 – – Narrows 2022 Revenue Growth and Earnings Per Share Guidance – – Announces Planned Divestiture of Avian Vaccine Business – WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #CRL–Charles River Laboratories International, Inc. (NYSE: CRL) today reported … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Transdermal Drug Delivery Market Analysis by Applications, by Type, by End user, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The transdermal drug delivery market size is estimated to be USD 6.5 billion in 2021 and is expected to witness a CAGR of 6.23% during the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Soft Tissue Sarcoma Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Soft Tissue Sarcoma pipeline products, Soft Tissue Sarcoma epidemiology, Soft Tissue Sarcoma market valuations and forecast, Soft Tissue Sarcoma drugs sales and competitive landscape in the US. The research is … [Read more…]

November 3rd online event, hosted by Wolters Kluwer, features industry experts from Brigham and Women’s Hospital in Boston, CVS Caremark, and the University of Kentucky School of Pharmacy –(BUSINESS WIRE)–Wolters Kluwer (AEX:WKL): What: Pharmacy Next: Safer, Affordable & Personalized, a Wolters Kluwer-hosted online panel of medical, retail pharmacy, and pharmacogenomics experts predicting the future of … [Read more…]

Next-generation of analytical reporting delivers fast return-on-investment by improving SPD throughput to increase surgical capacity FRANKLIN, Tenn.–(BUSINESS WIRE)–Sterile processing departments (SPDs) are under increased pressure to deliver more sterile trays to operating rooms in less time, but managers often lack the insight into where improvements can be made. The new CensisAI2 Productivity platform is the … [Read more…]

LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2022. Financial Summary and Highlights1 Revenue of $252.6 million for the quarter decreased 0.2 percent on a reported basis and increased 5.2 percent on a constant-currency basis, as compared to the prior-year period U.S. … [Read more…]

Assisting Lifestyle Changes as a Treatment for Hypertension TOKYO–(BUSINESS WIRE)–#App–CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx*1 solution treating hypertension, in Japan from September 1, 2022. Looking ahead, the app will be prescribed and provided … [Read more…]